Lenox Wealth Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
EHC
Lenox Wealth Advisors's NVO Position: Q2 2021 in Review
Lenox Wealth Advisors sold out of Novo Nordisk (NVO) in Q2 2021, closing a stake of 162 shares — an estimated $5K sold.
Lenox Wealth Advisors first reported a position in NVO in Q4 2014 and held it in 20 quarters. The position peaked at $51K in Q3 2015. 736 funds tracked by Wall St. Rank hold NVO as of Q2 2021.
- Lenox Wealth Advisors reported no remaining Novo Nordisk position as of Q2 2021 after selling out during the quarter.
- Lenox Wealth Advisors sold 162 Novo Nordisk shares in Q2 2021, an estimated $5K.
- Lenox Wealth Advisors first reported a position in Novo Nordisk in Q4 2014 and held it in 20 quarters.
- Lenox Wealth Advisors's Novo Nordisk position peaked at $51K in Q3 2015.
- 736 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2021.
Based on Lenox Wealth Advisors's 13F filing for Q2 2021, filed 8 Jul 2021.